The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Celsius Resources (ASX:CLA) has engaged DrillCorp Mining Resources to undertake a detailed geotechnical and hydrogeological drill run to update its Front-End Engineering and Design (FEED) and its feasibility study.

Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.

The geotechnical and hydrogeological drilling program will cover up to 2,300 metres when it gets started in June. Early cost estimates range up to around A$925,000.

Celsius executive director Mark van Kerkwijk joined HotCopper in a Watchlist interview to discuss the move and why it’s so key for the copper-gold explorer.

Join the discussion: See what HotCopper users are saying about Celsius Resources and be part of the conversations that move the markets.

The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.

cla by the numbers
More From The Market Online
AIZ plane

Air NZ up +1%, for some reason, even after suspending FY26 guidance

It’s only seen around $185,000 in trades share hands on Tuesday, but for some reason, at least one investor has thrown money at
HotCopper Daily Market Trends Graphic

Tuesday’s HotCopper trends: American T&A, Telix Pharma, Imugene, and other daily topics | March 10

It’s been a bounce-back day for Australian shares, with yesterday’s bloodbath somewhat pared by +1.5% gains across the day on Trump’s “peace” boasts.

Dreadnought Resources kicks off drilling at Metzkes Find under ‘find more gold faster’ strategy

Dreadnought Resources is ramping up its "finding more gold faster" strategy at the Illaara project in…

EVE Health Group to target global markets with reformulated drugs

EVE Health Group will test global markets after successfully completing R&D work on several reformulated drug…